Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction
Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-16:2 (2018) p. 342-348
Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different invitro models
Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-16:10 (2018) p. 2057-2069
Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis
Bron
Thrombosis and haemostasis : international journal for vascular biology and medicine - ISSN 0340-6245-117:8 (2017) p. 1498-1508
Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction
Bron
Journal of thrombosis and haemostasis - ISSN 1538-7933-13:12 (2015) p. 2227-2232
Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients
Bron
Clinical neurology and neurosurgery - ISSN 0303-8467-111:2 (2009) p. 165-170